Oncology provider strikes deal with DOJ in cartel probe
The Department of Justice has fined one of the country’s largest cancer treatment providers $100 million as part of a deferred prosecution agreement after the company admitted conspiring with a rival to eliminate competition.
Subscribe to Global Competition Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10